Afficher la notice abrégée

Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey

hal.structure.identifierAVENTIS PASTEUR SA
dc.contributor.authorVERDIER, F.
hal.structure.identifierMDS Pharma Services
dc.contributor.authorBURNETT, R.
hal.structure.identifierCentre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG]
dc.contributor.authorMICHELET-HABCHI, C.
hal.structure.identifierCentre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG]
dc.contributor.authorMORETTO, P.
hal.structure.identifierAVENTIS PASTEUR SA
dc.contributor.authorFIEVET-GROYNE, F.
hal.structure.identifierAVENTIS PASTEUR SA
dc.contributor.authorSAUZEAT, E.
dc.date.issued2005
dc.identifier.issn0264-410X
dc.description.abstractEnAluminium hydroxide and aluminium phosphate have been widely used as vaccine adjuvants with a good safety record for several decades. The recent observation in human deltoid muscle of macrophage aggregates containing aluminium hydroxide spicules and termed Macrophagic Myofasciitis (MMF) has encouraged research on aluminium salts. This study was conducted in order to further investigate the clearance of aluminium at the vaccine injection site and the features of induced histopathological lesions. Two groups of 12 monkeys were immunised in the quadriceps muscle with Diphtheria–Tetanus vaccines, which were adjuvanted with either aluminium hydroxide or aluminium phosphate. Three, six or twelve months after vaccination, four monkeys from each group were sacrificed and histopathological examination and aluminium assays were performed on quadriceps muscle sections. Histopathological lesions, similar to the MMF described in humans, were observed and were still present 3 months after aluminium phosphate and 12 months after aluminium hydroxide adjuvanted vaccine administration. An increase in aluminium concentration, more marked in the area of the lesions, was also observed at the 3- and 6-month time points. These findings were localised at the injection site and no similar changes were observed in the distal or proximal muscle fragments. We conclude from this study that aluminium adjuvanted vaccines administered by the intramuscular route trigger histopathological changes restricted to the area around the injection site which persist for several months but are not associated with abnormal clinical signs.
dc.language.isoen
dc.publisherElsevier
dc.title.enAluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey
dc.typeArticle de revue
dc.identifier.doi10.1016/j.vaccine.2004.09.012
dc.subject.halPhysique [physics]/Physique [physics]/Biophysique [physics.bio-ph]
dc.subject.halSciences du Vivant [q-bio]/Biologie animale/Médecine vétérinaire et santé animal
bordeaux.journalVaccine
bordeaux.page1359-1367
bordeaux.volume23
bordeaux.peerReviewedoui
hal.identifierin2p3-00153976
hal.version1
hal.popularnon
hal.audienceNon spécifiée
hal.origin.linkhttps://hal.archives-ouvertes.fr//in2p3-00153976v1
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Vaccine&rft.date=2005&rft.volume=23&rft.spage=1359-1367&rft.epage=1359-1367&rft.eissn=0264-410X&rft.issn=0264-410X&rft.au=VERDIER,%20F.&BURNETT,%20R.&MICHELET-HABCHI,%20C.&MORETTO,%20P.&FIEVET-GROYNE,%20F.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée